BR112015003353A2 - antiviral methods and use of an antiviral agent - Google Patents

antiviral methods and use of an antiviral agent

Info

Publication number
BR112015003353A2
BR112015003353A2 BR112015003353A BR112015003353A BR112015003353A2 BR 112015003353 A2 BR112015003353 A2 BR 112015003353A2 BR 112015003353 A BR112015003353 A BR 112015003353A BR 112015003353 A BR112015003353 A BR 112015003353A BR 112015003353 A2 BR112015003353 A2 BR 112015003353A2
Authority
BR
Brazil
Prior art keywords
antiviral
methods
agent
antiviral agent
antiviral methods
Prior art date
Application number
BR112015003353A
Other languages
Portuguese (pt)
Inventor
Xiang Liu Ding
Sup Yoon Ho
Toan Nguyen Quoc
Original Assignee
Univ Nanyang Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nanyang Tech filed Critical Univ Nanyang Tech
Publication of BR112015003353A2 publication Critical patent/BR112015003353A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR112015003353A 2012-08-14 2013-08-05 antiviral methods and use of an antiviral agent BR112015003353A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261682932P 2012-08-14 2012-08-14
PCT/SG2013/000329 WO2014027958A1 (en) 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent

Publications (1)

Publication Number Publication Date
BR112015003353A2 true BR112015003353A2 (en) 2017-12-05

Family

ID=50101349

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015003353A BR112015003353A2 (en) 2012-08-14 2013-08-05 antiviral methods and use of an antiviral agent

Country Status (4)

Country Link
KR (1) KR102257437B1 (en)
BR (1) BR112015003353A2 (en)
SG (2) SG11201500632VA (en)
WO (1) WO2014027958A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102007096B1 (en) * 2017-12-18 2019-08-02 경희대학교 산학협력단 Composition for preventing or treating hearing loss comprising Viscum ovalifolium extracts
US20220339241A1 (en) 2019-07-09 2022-10-27 Unichem Laboratories Ltd Stable formulations of recombinant proteins
CN113350482B (en) * 2021-05-31 2022-05-27 中国食品药品检定研究院 Application of phytohemagglutinin PHA-E in preparation of medicine for treating diseases caused by coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
KR101012507B1 (en) * 2008-01-08 2011-02-08 (주)디딤바이오텍 A composition for sanitary supplies comprising mucosal immunoadjuvant and a preparation method thereof
DE102011003478A1 (en) * 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antiviral agent containing recombinant mistletoe lectins

Also Published As

Publication number Publication date
WO2014027958A1 (en) 2014-02-20
KR102257437B1 (en) 2021-05-31
SG11201500632VA (en) 2015-02-27
KR20150042852A (en) 2015-04-21
SG10201701154RA (en) 2017-04-27

Similar Documents

Publication Publication Date Title
CL2015000640A1 (en) Hppd variants and methods of use
CR20150380A (en) POLYCHYCLIC CARBAMOILPIRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
CL2016000981A1 (en) Strigolactone formulations and their uses
EP3074754A4 (en) Microimager analysis system comprising optics and methods of use thereof
CO7030962A2 (en) Therapeutically active compounds and their methods of use
CO7010834A2 (en) Therapeutically active compounds and their methods of use
CL2015003441A1 (en) Compositions of serpina harness1 and their methods of use
SI3071696T1 (en) C/ebp alpha short activating rna compositions and methods of use
CL2015001266A1 (en) Antihemagglutinin antibodies and methods of use.
BR112014028366A2 (en) anti-ly6e and immunoconjugate antibodies and methods of use
BR112015001600A2 (en) emulsion and use of an ester
CO7000747A2 (en) Anti-lrp5 antibodies and methods of use
BR112015002331A2 (en) reversible thermochromic coating and method of use
HK1221416A1 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
EP2834421A4 (en) Stabilizing agents and methods of use thereof
SMT201600069B (en) COMPOSITIONS INCLUDING 15-HEPE AND METHODS OF USE OF THE SAME
HK1225645A1 (en) Pcv2b divergent vaccine composition and methods of use
BR112016004003A2 (en) TETRAZOLINONE COMPOUND AND USE OF IT
HK1222864A1 (en) Small molecule modulators of pcsk9 and methods of use thereof pcsk9
BR112015016548A2 (en) polymyxins, compositions, preparation methods and methods of use
CL2016000235A1 (en) Rorc2 inhibitors and their methods of use
DK3068505T3 (en) GAME SYSTEM AND PROCEDURE
CL2015001689A1 (en) Parvovirus 5a pig, methods of use and vaccine
CR20140362A (en) PHENYLIMIDAZOPIRAZOLES REPLACED AND ITS USE
BR112016004943A2 (en) medical device and use

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2450 DE 19-12-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.